NovoCure Limited (NVCR) Operating cash flow 2017–2026
NovoCure Limited (NVCR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.0MFY2026 · since FY2017: -$107.6M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$49.0M | -85.9% |
| FY2025 | -$26.4M | +64.0% |
| FY2024 | -$73.3M | -338.2% |
| FY2023 | $30.8M | -62.8% |
| FY2022 | $82.8M | -16.5% |
| FY2021 | $99.1M | +272.5% |
| FY2020 | $26.6M | +1527.3% |
| FY2019 | -$1.9M | +94.4% |
| FY2018 | -$33.1M | +69.2% |
| FY2017 | -$107.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice